Search results
Analysts Set Denali Therapeutics Inc. (NASDAQ:DNLI) PT at $40.22
ETF DAILY NEWS· 5 days agoDenali Therapeutics Inc. (NASDAQ:DNLI – Get Free Report) has received an average rating of “Moderate Buy” from the nine ratings firms that are covering the company, MarketBeat.com reports. Wedbush ...